A preliminary study on Fructus Aurantii extract against hepatocarcinoma via glycolysis and PD-1/PD-L1 pathway

MLA

Xi Luo, et al. “A Preliminary Study on Fructus Aurantii Extract against Hepatocarcinoma via Glycolysis and PD-1/PD-L1 Pathway.” Pharmacological Research - Modern Chinese Medicine, vol. 2, Mar. 2022, p. 100051. EBSCOhost, https://doi.org/10.1016/j.prmcm.2022.100051.

APA

Xi Luo, Jia He, Yong-rui Bao, Shuai Wang, Tian-jiao Li, Jia-peng Leng, Xian-sheng Meng, & Yan Zhang. (2022). A preliminary study on Fructus Aurantii extract against hepatocarcinoma via glycolysis and PD-1/PD-L1 pathway. Pharmacological Research - Modern Chinese Medicine, 2, 100051. https://doi.org/10.1016/j.prmcm.2022.100051

Chicago

Xi Luo, Jia He, Yong-rui Bao, Shuai Wang, Tian-jiao Li, Jia-peng Leng, Xian-sheng Meng, and Yan Zhang. 2022. “A Preliminary Study on Fructus Aurantii Extract against Hepatocarcinoma via Glycolysis and PD-1/PD-L1 Pathway.” Pharmacological Research - Modern Chinese Medicine 2 (March): 100051. doi:10.1016/j.prmcm.2022.100051.